US Patent 11981658 Substituted aminopyridine compounds as EGFR inhibitors
Article
Patent abstract
Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.